Health
Astra Gets EU Approval for Another Use of Lung Cancer Drug
Tagrisso won clearance in the European Union for an advanced form of non-small cell lung cancer.
Source: BusinessWireAstraZeneca Plc’s drug Tagrisso won clearance in the European Union for an advanced form of non-small cell lung cancer, extending the revenue potential for the drugmaker’s top-selling cancer medicine.
The treatment was approved after a study showed it reduced the risk of disease progression or death by 84% in patients with with locally advanced non-small cell lung cancer whose tumors have a specific genetic mutation and can’t be operated.